Clinical trial · Observational
Ledderhose Disease - Long Term Effects of Radiotherapy Treatment. LedRad LTE - Study
NCT04229147CI-TRIAL-00074495completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the LedRad LTE study is to determine the current complaints, late side effects and satisfaction of patients who were treated with radiotherapy for Ledderhose disease at least two years ago.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ledderhose Disease | Plantar Fibromatosis | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Current pain
- timeFrame
- at least 2 years after treatment
- description
- Determine pain with the numeric rating scale. A 11-point pain scale ranging from 0=no pain to 10=worst pain
Secondary outcomes (4)
- measure
- Worst pain
- timeFrame
- at least 2 years after treatment
- description
- Determine pain with the numeric rating scale. A 11-point pain scale ranging from 0=no pain to 10=worst pain
- measure
- Quality of Life
- timeFrame
- at least 2 years after treatment
- description
- Assess the impact on quality of life of the treatment with radiotherapy for this study population with the EURO-Qol-5D-5L
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Patients treated with radiotherapy for Ledderhose disease at the UMCG at least 2 years ago
References
Publications (0)
Data not yet available
No reference posted for this study.